Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+11.85%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$41.8B
AUM Growth
+$1.48B
(+3.7%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
19.13%
Holding
1,140
New
93
Increased
265
Reduced
373
Closed
167
Top Buys
| 1 |
Chipotle Mexican Grill
CMG
|
$183M |
| 2 |
Boeing
BA
|
$129M |
| 3 |
Occidental Petroleum
OXY
|
$115M |
| 4 |
argenx
ARGX
|
$109M |
| 5 |
MetLife
MET
|
$100M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$349M |
| 2 |
Burlington
BURL
|
$236M |
| 3 |
Textron
TXT
|
$167M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$166M |
| 5 |
Honeywell
HON
|
$153M |
Sector Composition
| 1 | Technology | 22.51% |
| 2 | Healthcare | 18.38% |
| 3 | Financials | 16.36% |
| 4 | Industrials | 8.15% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amylyx Pharmaceuticals
AMLX
$885M
| $70.5M | 0.17% |
1,909,201
+559,201
| +41% | +$20.7M |
|
152
Air Products & Chemicals
APD
$64.5B
| $69.6M | 0.17% |
225,640
-300
| -0.1% | -$92.5K |
|
153
Zoetis
ZTS
$67.6B
| $69.5M | 0.17% |
474,024
-2,900
| -0.6% | -$425K |
|
154
Mettler-Toledo International
MTD
$26.3B
| $68.9M | 0.16% |
47,657
+24,700
| +108% | +$35.7M |
|
155
Noble Corp
NE
$4.56B
| $68.9M | 0.16% |
1,826,134
+949,229
| +108% | +$35.8M |
|
156
Starbucks
SBUX
$98.8B
| $68.7M | 0.16% |
692,709
-907,150
| -57% | -$90M |
|
|
EXE
157
Expand Energy Corporation Common Stock
EXE
$22.9B
| $68M | 0.16% |
720,812
-190,000
| -21% | -$17.9M |
|
158
Micron Technology
MU
$136B
| $67.4M | 0.16% |
1,348,930
-38,200
| -3% | -$1.91M |
|
159
Colgate-Palmolive
CL
$67.3B
| $67M | 0.16% |
849,934
+306,114
| +56% | +$24.1M |
|
160
CSX Corp
CSX
$60.8B
| $66.9M | 0.16% |
2,158,404
-137,832
| -6% | -$4.27M |
|
161
F5
FFIV
$18B
| $66.9M | 0.16% |
465,900
-46,800
| -9% | -$6.72M |
|
162
Humana
HUM
$37.6B
| $66M | 0.16% |
128,810
-100
| -0.1% | -$51.2K |
|
163
Allegion
ALLE
$14.6B
| $63.4M | 0.15% |
602,371
+162,900
| +37% | +$17.1M |
|
164
Crown Castle
CCI
$41.4B
| $63.1M | 0.15% |
464,964
+23,804
| +5% | +$3.23M |
|
165
Applied Materials
AMAT
$127B
| $62.9M | 0.15% |
646,001
-15,600
| -2% | -$1.52M |
|
166
Lennox International
LII
$19.8B
| $62.9M | 0.15% |
+262,766
| New | +$62.9M |
|
167
Biogen
BIIB
$20.3B
| $61.6M | 0.15% |
222,599
-25,200
| -10% | -$6.98M |
|
168
CME Group
CME
$96.3B
| $61.5M | 0.15% |
365,931
-300
| -0.1% | -$50.4K |
|
169
Bristol-Myers Squibb
BMY
$95.2B
| $61.4M | 0.15% |
853,766
-1,372,229
| -62% | -$98.7M |
|
|
VMW
170
DELISTED
VMware, Inc
VMW
| $60.4M | 0.14% |
491,755
-41,585
| -8% | -$5.1M |
|
171
Moderna
MRNA
$9.41B
| $60.4M | 0.14% |
336,016
+3,300
| +1% | +$593K |
|
172
Monster Beverage
MNST
$62B
| $59.6M | 0.14% |
1,173,964
-341,000
| -23% | -$17.3M |
|
173
Valaris
VAL
$3.57B
| $59.6M | 0.14% |
880,716
+752,947
| +589% | +$50.9M |
|
174
Schlumberger
SLB
$53.4B
| $59.5M | 0.14% |
1,112,267
-467,600
| -30% | -$25M |
|
|
175
Textron
TXT
$14.4B
| $58.7M | 0.14% |
829,345
-2,358,397
| -74% | -$167M |
|